Mironid Limited is an innovative new drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. This allows us to access multiple therapeutic areas for exploitation. Our current drug discovery pipeline is aimed at developing novel treatments for degenerative kidney diseases, chronic inflammatory diseases and cancer.
Location: United Kingdom, Scotland
Employees: 11-50
Total raised: $6.31M
Founded date: 2015
Investors 2
| Date | Name | Website |
| 18.08.2021 | BioGenerat... | biogenerat... |
| - | Epidarex C... | epidarex.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.08.2026 | Series B | $45.83M | - |
| 20.06.2016 | Series A | $6.31M | - |
Mentions in press and media 7
| Date | Title | Description |
| 08.09.2026 | DIGIT Deal Roundup | August 2026 | Welcome to August 2026’s DIGIT Deal Roundup. The month was full of major investment stories, with Scotland seeing winning deals from the AI race in terms of data centre deals and chip funding. Construction, space, and biotech also saw major... |
| 10.08.2026 | European tech weekly recap: €1B in deals and July's highlights | Last week, we tracked more than 35 tech funding deals worth over €1 billion and 5 exits, M&A transactions, rumours, and related news stories across Europe. 📊 Our latest monthly report, published last week, shows that European tech start... |
| 05.08.2026 | Glasgow Biotech Mironid Secures £34m Series B Funding | Glasgow-based biopharmaceutical company Mironid has raised £34m in a Series B funding round, which includes an £8.4m equity investment from the Scottish National Investment Bank (SNIB). SNIB joins existing investors, including Roche Venture... |
| 13.09.2023 | Mironid Extends Series A Funding; £35M Raised To Date | Mironid, a Glasgow, UK-based biopharmaceutical company developing small molecule therapeutics, extended its Series A funding. The round, which brought the total amount raised to date to £35M, was led by Roche Venture Fund with participation... |
| 20.06.2016 | Drug Discovery Company Mironid Closes £4.3M Series A Funding | Mironid Ltd, a Glasgow, Scotland, UK-based drug discovery company, closed its £4.3m ($6.2m) Series A funding round. The round was led by Epidarex Capital with participation from the Scottish Investment Bank, on behalf of Scottish Enterprise... |
| 20.06.2016 | Mironid Closes £4.3M ($6.2M) Series A Financing | GLASGOW, Scotland--(BUSINESS WIRE)--Mironid Ltd, a leader in cell signalling directed drug development, today announced the closing of its Series A funding round of £4.3 million ($6.2 million), which will support the Company’s internal rese... |
| - | Mironid | “Mironid” |